AU516531B2 - Method and composition forthe therapy of cerebral circulatory diseases - Google Patents

Method and composition forthe therapy of cerebral circulatory diseases

Info

Publication number
AU516531B2
AU516531B2 AU22554/77A AU2255477A AU516531B2 AU 516531 B2 AU516531 B2 AU 516531B2 AU 22554/77 A AU22554/77 A AU 22554/77A AU 2255477 A AU2255477 A AU 2255477A AU 516531 B2 AU516531 B2 AU 516531B2
Authority
AU
Australia
Prior art keywords
therapy
circulatory diseases
cerebral circulatory
composition forthe
forthe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU22554/77A
Other languages
English (en)
Other versions
AU2255477A (en
Inventor
D Vegezzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2255477A publication Critical patent/AU2255477A/en
Application granted granted Critical
Publication of AU516531B2 publication Critical patent/AU516531B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22554/77A 1976-02-23 1977-02-22 Method and composition forthe therapy of cerebral circulatory diseases Expired AU516531B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH217776 1976-02-23
CHCH2177/76 1976-02-23

Publications (2)

Publication Number Publication Date
AU2255477A AU2255477A (en) 1978-08-31
AU516531B2 true AU516531B2 (en) 1981-06-11

Family

ID=4227685

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22554/77A Expired AU516531B2 (en) 1976-02-23 1977-02-22 Method and composition forthe therapy of cerebral circulatory diseases

Country Status (9)

Country Link
AU (1) AU516531B2 (pt)
BE (1) BE851702A (pt)
DE (1) DE2707763A1 (pt)
FR (1) FR2341305A1 (pt)
GB (1) GB1569036A (pt)
GR (1) GR70334B (pt)
NL (1) NL7701869A (pt)
PT (1) PT66201B (pt)
ZA (1) ZA771079B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762277A (en) * 1980-06-23 1982-04-15 Ciba Geigy Ag Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
NZ211545A (en) * 1984-04-11 1987-09-30 Ici Australia Ltd Composition having particulate trace element suspended in matrix of solid polyethylene glycol
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
RU2525433C2 (ru) * 2011-10-05 2014-08-10 Общество С Ограниченной Ответственностью "Фарма Старт" Лекарственный препарат винкамина в форме матричных таблеток для улучшения мозгового кровообращения и способ его изготовления

Also Published As

Publication number Publication date
PT66201B (fr) 1978-11-07
GB1569036A (en) 1980-06-11
DE2707763A1 (de) 1977-09-01
GR70334B (pt) 1982-09-17
FR2341305A1 (fr) 1977-09-16
BE851702A (fr) 1977-06-16
NL7701869A (nl) 1977-08-25
FR2341305B1 (pt) 1981-01-16
PT66201A (fr) 1977-03-01
ZA771079B (en) 1978-01-25
AU2255477A (en) 1978-08-31

Similar Documents

Publication Publication Date Title
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
GB2000433A (en) Insole and method of producing the same
JPS52100784A (en) Pacemaker and method of producing same
ZA791728B (en) Cerebral therapeutic agent and its use
JPS5241498A (en) Blood dialyzer and method of producing same
JPS53109757A (en) Slipper and method of producing same
ZA774456B (en) Disposable undergarments and method of manufacture
IL48840A0 (en) A therapeutic system in the form of a bandage and method of making the same
JPS5479991A (en) Blood control standard and method of producing same
AU513619B2 (en) Method and composition for relief of back pain
CA1027356A (en) Tennis shoe outsole and method of making the same
IL64146A0 (en) Derivatives of thieno-pyridinone,the method of their preparation and their therapeutic use
JPS52133989A (en) Novel aminopiperidines and method of their preparation and medical composition thereof
GB1553424A (en) Method of treating protozal diseases
AU516531B2 (en) Method and composition forthe therapy of cerebral circulatory diseases
JPS5672100A (en) Manufacture of titanium tanning agent and method therefor
AU513234B2 (en) Method of treatment with 2-iminothiazolidines and thiazolines
PH12964A (en) Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases
IL48787A (en) Slow and continuois release pharmaceutical preparations comprising phetnolamine for the treatment of circulatory disorders
AU517648B2 (en) Method and kit forthe preparation of radiopharmaceuticals
SU638339A1 (ru) Способ лечени сосудистых заболеваний конечностей
SU629920A1 (ru) Способ оперативного доступа к клиновидной пазухе и турецкому седлу
JPS53123254A (en) Whole rubber shoes and method of producing same
SU694351A1 (ru) Способ абразивной обработки
GB1522577A (en) Derivative of thiodecan and its application in therapy